FDA-approved Crohn's treatments include biologic therapies (infliximab, adalimumab, vedolizumab, ustekinumab, risankizumab), JAK inhibitors (upadacitinib), corticosteroids for induction (budesonide, prednisone), and immunomodulators (azathioprine, methotrexate)
Rodbard HW, Lingvay I, Reed J, De La Rosa R, Rose L, Sugimoto D, Araki E, Chu P-L, Wijayasinghe N, Norwood P
Mounjaro: Fast-Acting Weight Loss with a Dual Approach Mounjaro (tirzepatide) targets both GLP-1 and GIP receptors , delivering a dual-action effect that controls appetite and boosts insulin sensitivity
Portion Control Strategies for Pasta on Semaglutide The most successful semaglutide patients report that portion instinct shifts automaticallythey plate less pasta without conscious effort because their appetite signals change
Weight loss is gradual and varies from person to person
Observations with GLP-1 Agonists: Antibody Reduction: The speaker has witnessed significant reductions in Hashimoto's antibodies among patients using GLP-1agonists, indicating their potential role in managing auto-immune thyroid conditions